> top > docs > PubMed:4761608 > annotations

PubMed:4761608 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-120 Sentence denotes Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease.
T2 121-294 Sentence denotes Plasma levels of circulating carcinoembryonic antigen (CEA) were measured by zirconyl phosphate gel radioimmunoassay in 112 patients with chronic inflammatory bowel disease.
T3 295-439 Sentence denotes The levels were then related to category, extent, duration, and severity of disease, as well as to the ages and surgical status of the patients.
T4 440-675 Sentence denotes The distribution of CEA levels and their mean values were significantly raised over the levels in 33 normal control subjects, and were similar among patients with ulcerative colitis compared with those with granulomatous bowel disease.
T5 676-737 Sentence denotes Positive values were defined as those in excess of 2.5 ng/ml.
T6 738-900 Sentence denotes Positive assays occurred in 42% of ulcerative colitis patients, in 38% of Crohn's disease patients, and in 40% of the total group with inflammatory bowel disease.
T7 901-954 Sentence denotes Among normal control subjects, only 3% were positive.
T8 955-1154 Sentence denotes Among inflammatory bowel disease patients, positive CEA assays occurred more frequently with more severe disease, more extensive anatomical involvement, younger ages, and shorter duration of disease.
T9 1155-1325 Sentence denotes Those patients who had undergone total colectomy showed levels of circulating CEA and frequency of CEA positivity similar to those of an age-matched normal control group.
T10 1326-1434 Sentence denotes Levels of CEA did not correspond with known cancer risk factors in patients with inflammatory bowel disease.
T11 1435-1713 Sentence denotes Although rising or persisting plasma CEA values unrelated to severity and extent of disease may indicate an unfavourable prognosis in cancer, this study shows that a single CEA value in patients with chronic inflammatory bowel disease is not a reliable indicator of cancer risk.
T1 0-120 Sentence denotes Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease.
T2 121-294 Sentence denotes Plasma levels of circulating carcinoembryonic antigen (CEA) were measured by zirconyl phosphate gel radioimmunoassay in 112 patients with chronic inflammatory bowel disease.
T3 295-439 Sentence denotes The levels were then related to category, extent, duration, and severity of disease, as well as to the ages and surgical status of the patients.
T4 440-675 Sentence denotes The distribution of CEA levels and their mean values were significantly raised over the levels in 33 normal control subjects, and were similar among patients with ulcerative colitis compared with those with granulomatous bowel disease.
T5 676-737 Sentence denotes Positive values were defined as those in excess of 2.5 ng/ml.
T6 738-900 Sentence denotes Positive assays occurred in 42% of ulcerative colitis patients, in 38% of Crohn's disease patients, and in 40% of the total group with inflammatory bowel disease.
T7 901-954 Sentence denotes Among normal control subjects, only 3% were positive.
T8 955-1154 Sentence denotes Among inflammatory bowel disease patients, positive CEA assays occurred more frequently with more severe disease, more extensive anatomical involvement, younger ages, and shorter duration of disease.
T9 1155-1325 Sentence denotes Those patients who had undergone total colectomy showed levels of circulating CEA and frequency of CEA positivity similar to those of an age-matched normal control group.
T10 1326-1434 Sentence denotes Levels of CEA did not correspond with known cancer risk factors in patients with inflammatory bowel disease.
T11 1435-1713 Sentence denotes Although rising or persisting plasma CEA values unrelated to severity and extent of disease may indicate an unfavourable prognosis in cancer, this study shows that a single CEA value in patients with chronic inflammatory bowel disease is not a reliable indicator of cancer risk.